Go Pro

Ryan Specialty (RYAN) Competitors

Ryan Specialty logo
$43.28 +0.24 (+0.56%)
As of 08/21/2026 03:58 PM Eastern

RYAN vs. AJG, BRO, WTW, ERIE, and HGTY

Should you buy Ryan Specialty stock or one of its competitors? Ryan Specialty's main competitors and comparable companies include Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Erie Indemnity (ERIE), and Hagerty (HGTY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "insurance brokers" industry.

How does Ryan Specialty compare to Arthur J. Gallagher & Co.?

Ryan Specialty (NYSE:RYAN) and Arthur J. Gallagher & Co. (NYSE:AJG) are both large-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

Ryan Specialty presently has a consensus target price of $53.86, suggesting a potential upside of 24.45%. Arthur J. Gallagher & Co. has a consensus target price of $290.28, suggesting a potential upside of 10.27%. Given Ryan Specialty's higher probable upside, equities analysts clearly believe Ryan Specialty is more favorable than Arthur J. Gallagher & Co..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Arthur J. Gallagher & Co.
0 Sell rating(s)
5 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.74

Ryan Specialty has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Arthur J. Gallagher & Co. has a beta of 0.5, indicating that its stock price is 50% less volatile than the broader market.

Arthur J. Gallagher & Co. has higher revenue and earnings than Ryan Specialty. Arthur J. Gallagher & Co. is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.63$63.40M$0.7260.11
Arthur J. Gallagher & Co.$13.94B4.84$1.49B$6.0343.66

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 85.5% of Arthur J. Gallagher & Co. shares are owned by institutional investors. 52.0% of Ryan Specialty shares are owned by insiders. Comparatively, 1.4% of Arthur J. Gallagher & Co. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Arthur J. Gallagher & Co. had 12 more articles in the media than Ryan Specialty. MarketBeat recorded 14 mentions for Arthur J. Gallagher & Co. and 2 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 1.23 beat Arthur J. Gallagher & Co.'s score of 0.74 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Arthur J. Gallagher & Co.
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Arthur J. Gallagher & Co. has a net margin of 9.96% compared to Ryan Specialty's net margin of 7.55%. Ryan Specialty's return on equity of 43.97% beat Arthur J. Gallagher & Co.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty7.55% 43.97% 4.78%
Arthur J. Gallagher & Co. 9.96%13.28%4.03%

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Arthur J. Gallagher & Co. pays an annual dividend of $2.80 per share and has a dividend yield of 1.1%. Ryan Specialty pays out 72.2% of its earnings in the form of a dividend. Arthur J. Gallagher & Co. pays out 46.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has raised its dividend for 1 consecutive years and Arthur J. Gallagher & Co. has raised its dividend for 15 consecutive years.

Summary

Arthur J. Gallagher & Co. beats Ryan Specialty on 11 of the 19 factors compared between the two stocks.

How does Ryan Specialty compare to Brown & Brown?

Ryan Specialty (NYSE:RYAN) and Brown & Brown (NYSE:BRO) are both large-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Ryan Specialty has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, Brown & Brown has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 71.0% of Brown & Brown shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by insiders. Comparatively, 13.1% of Brown & Brown shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Brown & Brown had 10 more articles in the media than Ryan Specialty. MarketBeat recorded 12 mentions for Brown & Brown and 2 mentions for Ryan Specialty. Brown & Brown's average media sentiment score of 1.61 beat Ryan Specialty's score of 1.23 indicating that Brown & Brown is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Brown & Brown
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Brown & Brown pays an annual dividend of $0.66 per share and has a dividend yield of 0.9%. Ryan Specialty pays out 72.2% of its earnings in the form of a dividend. Brown & Brown pays out 20.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years. Ryan Specialty is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Brown & Brown has a net margin of 17.75% compared to Ryan Specialty's net margin of 7.55%. Ryan Specialty's return on equity of 43.97% beat Brown & Brown's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty7.55% 43.97% 4.78%
Brown & Brown 17.75%13.17%5.56%

Ryan Specialty presently has a consensus target price of $53.86, indicating a potential upside of 24.45%. Brown & Brown has a consensus target price of $76.80, indicating a potential upside of 5.36%. Given Ryan Specialty's stronger consensus rating and higher probable upside, equities research analysts plainly believe Ryan Specialty is more favorable than Brown & Brown.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Brown & Brown
1 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.16

Brown & Brown has higher revenue and earnings than Ryan Specialty. Brown & Brown is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.63$63.40M$0.7260.11
Brown & Brown$5.90B4.13$1.05B$3.1722.99

Summary

Ryan Specialty and Brown & Brown tied by winning 9 of the 18 factors compared between the two stocks.

How does Ryan Specialty compare to Willis Towers Watson Public?

Ryan Specialty (NYSE:RYAN) and Willis Towers Watson Public (NASDAQ:WTW) are both large-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Willis Towers Watson Public pays an annual dividend of $3.84 per share and has a dividend yield of 1.1%. Ryan Specialty pays out 72.2% of its earnings in the form of a dividend. Willis Towers Watson Public pays out 23.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years and Willis Towers Watson Public has increased its dividend for 8 consecutive years.

Willis Towers Watson Public has higher revenue and earnings than Ryan Specialty. Willis Towers Watson Public is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.63$63.40M$0.7260.11
Willis Towers Watson Public$9.71B3.27$1.61B$16.2621.03

Ryan Specialty currently has a consensus price target of $53.86, suggesting a potential upside of 24.45%. Willis Towers Watson Public has a consensus price target of $369.38, suggesting a potential upside of 8.01%. Given Ryan Specialty's higher probable upside, equities research analysts plainly believe Ryan Specialty is more favorable than Willis Towers Watson Public.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Willis Towers Watson Public
0 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Willis Towers Watson Public had 18 more articles in the media than Ryan Specialty. MarketBeat recorded 20 mentions for Willis Towers Watson Public and 2 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 1.23 beat Willis Towers Watson Public's score of 0.89 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Willis Towers Watson Public
4 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Ryan Specialty has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Willis Towers Watson Public has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

Willis Towers Watson Public has a net margin of 15.49% compared to Ryan Specialty's net margin of 7.55%. Ryan Specialty's return on equity of 43.97% beat Willis Towers Watson Public's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty7.55% 43.97% 4.78%
Willis Towers Watson Public 15.49%22.19%6.00%

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 93.1% of Willis Towers Watson Public shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by insiders. Comparatively, 0.4% of Willis Towers Watson Public shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Willis Towers Watson Public beats Ryan Specialty on 12 of the 20 factors compared between the two stocks.

How does Ryan Specialty compare to Erie Indemnity?

Erie Indemnity (NASDAQ:ERIE) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

In the previous week, Erie Indemnity and Erie Indemnity both had 2 articles in the media. Erie Indemnity's average media sentiment score of 1.32 beat Ryan Specialty's score of 1.23 indicating that Erie Indemnity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Erie Indemnity
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ryan Specialty
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

33.7% of Erie Indemnity shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 45.8% of Erie Indemnity shares are held by company insiders. Comparatively, 52.0% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Erie Indemnity pays an annual dividend of $5.85 per share and has a dividend yield of 2.2%. Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Erie Indemnity pays out 53.0% of its earnings in the form of a dividend. Ryan Specialty pays out 72.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Erie Indemnity has increased its dividend for 36 consecutive years and Ryan Specialty has increased its dividend for 1 consecutive years. Erie Indemnity is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Erie Indemnity has a net margin of 14.01% compared to Ryan Specialty's net margin of 7.55%. Ryan Specialty's return on equity of 43.97% beat Erie Indemnity's return on equity.

Company Net Margins Return on Equity Return on Assets
Erie Indemnity14.01% 21.09% 14.59%
Ryan Specialty 7.55%43.97%4.78%

Erie Indemnity has higher revenue and earnings than Ryan Specialty. Erie Indemnity is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Erie Indemnity$4.07B3.01$559.34M$11.0423.99
Ryan Specialty$3.05B3.63$63.40M$0.7260.11

Ryan Specialty has a consensus price target of $53.86, indicating a potential upside of 24.45%. Given Ryan Specialty's stronger consensus rating and higher probable upside, analysts plainly believe Ryan Specialty is more favorable than Erie Indemnity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Erie Indemnity
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37

Erie Indemnity has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

Summary

Erie Indemnity and Ryan Specialty tied by winning 9 of the 18 factors compared between the two stocks.

How does Ryan Specialty compare to Hagerty?

Ryan Specialty (NYSE:RYAN) and Hagerty (NYSE:HGTY) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

In the previous week, Hagerty had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 4 mentions for Hagerty and 2 mentions for Ryan Specialty. Ryan Specialty's average media sentiment score of 1.23 beat Hagerty's score of 0.69 indicating that Ryan Specialty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hagerty
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 20.5% of Hagerty shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by insiders. Comparatively, 3.7% of Hagerty shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ryan Specialty has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Hagerty has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market.

Ryan Specialty has a net margin of 7.55% compared to Hagerty's net margin of 1.81%. Ryan Specialty's return on equity of 43.97% beat Hagerty's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty7.55% 43.97% 4.78%
Hagerty 1.81%5.15%1.58%

Ryan Specialty presently has a consensus target price of $53.86, suggesting a potential upside of 24.45%. Hagerty has a consensus target price of $14.00, suggesting a potential upside of 7.20%. Given Ryan Specialty's higher probable upside, analysts plainly believe Ryan Specialty is more favorable than Hagerty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
1 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.37
Hagerty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.60

Ryan Specialty has higher revenue and earnings than Hagerty. Ryan Specialty is trading at a lower price-to-earnings ratio than Hagerty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$3.05B3.63$63.40M$0.7260.11
Hagerty$1.46B3.08$49.02M$0.09145.11

Summary

Ryan Specialty beats Hagerty on 12 of the 17 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyInsurance IndustryFinance SectorNYSE Exchange
Market Cap$11.07B$19.29B$13.63B$24.31B
Dividend Yield1.20%3.30%5.89%3.70%
P/E Ratio60.1115.7929.6130.31
Price / Sales3.6330.80521.6220.99
Price / Cash13.4112.5638.1932.49
Price / Book10.902.072.186.77
Net Income$63.40M$1.80B$1.31B$1.07B
7 Day Performance3.66%-0.59%-0.30%-0.65%
1 Month Performance8.22%3.47%2.37%3.38%
1 Year Performance-26.63%8.97%9.68%14.90%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYAN
Ryan Specialty
4.9648 of 5 stars
$43.28
+0.6%
$53.86
+24.4%
-26.6%$11.07B$3.05B60.116,110
AJG
Arthur J. Gallagher & Co.
4.5104 of 5 stars
$247.38
-1.5%
$289.17
+16.9%
-13.1%$64.39B$13.94B41.0272,000
BRO
Brown & Brown
3.8599 of 5 stars
$68.77
-2.5%
$76.47
+11.2%
-24.5%$23.60B$5.90B21.697,905
WTW
Willis Towers Watson Public
4.504 of 5 stars
$326.06
-1.7%
$363.50
+11.5%
+0.8%$30.80B$9.71B20.0546,900
ERIE
Erie Indemnity
3.5894 of 5 stars
$247.75
-3.2%
N/A-27.7%$11.82B$4.07B22.446,667

Related Companies and Tools


This page (NYSE:RYAN) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners